Medical Device Weekly Perspective

Research evidence excerpt

Medical Device Weekly Perspective

Not Rated (NR): The rating, price targets and estimates have been removed due to applicable legal, regulatory or policy constraints

which may include when RBC Capital Markets is acting in an advisory capacity involving the company.

Risk Rating

The Speculative risk rating reflects a security's lower level of financial or operating predictability, illiquid share trading volumes,

high balance sheet leverage, or limited operating history that result in a higher expectation of financial and/or stock price volatility.

Distribution of ratings

For the purpose of ratings distributions, regulatory rules require member firms to assign ratings to one of three rating categories -

Buy, Hold/Neutral, or Sell - regardless of a firm's own rating categories. Although RBC Capital Markets' ratings of Outperform (O),

Sector Perform (SP), and Underperform (U) most closely correspond to Buy, Hold/Neutral and Sell, respectively, the meanings are

not the same because our ratings are determined on a relative basis.

RBC Capital Markets, Equity Research

As of 31-Mar-2026

Investment Banking

Serv./Past 12 Mos.

Rating Count Percent Count Percent

BUY [Outperform] 899 57.52 286 31.81

HOLD [Sector Perform] 612 39.16 153 25.00

SELL [Underperform] 52 3.33 5 9.62

Conflicts policy

RBC Capital Markets Policy for Managing Conflicts of Interest in Relation to Investment Research is available from us on request.

To access our current policy, clients should refer to

https://www.rbccm.com/global/file-414164.pdf

or send a request to RBC Capital Markets Research Publishing, P.O. Box 50, 200 Bay Street, Royal Bank Plaza, 29th Floor, South

Tower, Toronto, Ontario M5J 2W7. We reserve the right to amend or supplement this policy at any time.

Dissemination of research